Sandy Cove Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
7,731
+1,240
+19% +$289K 0.49% 33
2026
Q1
$1.59M Sell
6,491
-315
-5% -$73.4K 0.47% 31
2025
Q4
$1.41M Buy
6,806
+140
+2% +$27.7K 0.42% 32
2025
Q3
$1.24M Buy
6,666
+143
+2% +$24.5K 0.4% 40
2025
Q2
$996K Buy
6,523
+307
+5% +$47.2K 0.36% 44
2025
Q1
$1.03M Buy
6,216
+482
+8% +$75.4K 0.41% 40
2024
Q4
$829K Buy
5,734
+74
+1% +$11.5K 0.33% 49
2024
Q3
$917K Sell
5,660
-410
-7% -$65.3K 0.37% 44
2024
Q2
$887K Buy
6,070
+473
+8% +$70.3K 0.39% 41
2024
Q1
$885K Buy
5,597
+238
+4% +$37.9K 0.41% 45
2023
Q4
$840K Sell
5,359
-73
-1% -$11.2K 0.43% 42
2023
Q3
$846K Buy
5,432
+11
+0.2% +$1.81K 0.49% 40
2023
Q2
$897K Buy
5,421
+1,880
+53% +$303K 0.51% 39
2023
Q1
$549K Sell
3,541
-87
-2% -$14K 0.4% 46
2022
Q4
$641K Sell
3,628
-75
-2% -$12.9K 0.52% 37
2022
Q3
$605K Buy
3,703
+60
+2% +$10.2K 0.54% 32
2022
Q2
$647K Hold
3,643
0.59% 32
2022
Q1
$646K Buy
3,643
+164
+5% +$27.9K 0.54% 32
2021
Q4
$595K Buy
+3,479
New +$570K 0.5% 38

Other funds holding JNJ

Sandy Cove Advisors's JNJ Position: Q2 2026 in Review

Sandy Cove Advisors increased its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, buying an estimated $289K and bringing the position to 7,731 shares worth $1.96M. The position accounts for 0.49% of the portfolio, ranked #33.

Sandy Cove Advisors first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 1,200 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sandy Cove Advisors held 7,731 shares of Johnson & Johnson worth $1.96M as of Q2 2026.
  • Sandy Cove Advisors bought 1,240 Johnson & Johnson shares in Q2 2026, an estimated $289K.
  • Johnson & Johnson made up 0.49% of Sandy Cove Advisors's portfolio in Q2 2026, its #33 holding.
  • Sandy Cove Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 1,200 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.